Windsor Capital Management’s St Jude Medical STJ Stock Holding History

Windsor Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,531	Closed	-$363K	–	118
2016 Q4	$363K	Hold	4,531	–	–	0.2%	91
2016 Q3	$361K	Hold	4,531	–	–	0.2%	96
2016 Q2	$353K	Hold	4,531	–	–	0.21%	92
2016 Q1	$249K	Buy	+4,531	New	+$247K	0.15%	97

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Windsor Capital Management's STJ Position: Q1 2017 in Review

Windsor Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,531 shares — an estimated $363K sold.

Windsor Capital Management first reported a position in STJ in Q1 2016 and held it in 4 quarters. The position peaked at $363K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Windsor Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Windsor Capital Management sold 4,531 St Jude Medical shares in Q1 2017, an estimated $363K.
Windsor Capital Management first reported a position in St Jude Medical in Q1 2016 and held it in 4 quarters.
Windsor Capital Management's St Jude Medical position peaked at $363K in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Windsor Capital Management's 13F filing for Q1 2017, filed 9 May 2017.